3-Hydroxyphencyclidine (3-HPC), a derivative of phencyclidine (PCP), is increasingly attracting clinical focus due to initial evidence suggesting distinct biological characteristics. Present analyses demonstrate that 3-HPC may display independent effects on the brain system, arguably contributing to some of the unexpected check here manifestations